Thomas D. Schmittgen: h-index, Total Citations, and Citation Map
Thomas D. Schmittgen's h-index is 56 (105 i10-index, 257,652+ total citations across 3+ publications) according to Google Scholar as of May 2026. Thomas D. Schmittgen is affiliated with Professor of Pharmaceutics University of Florida.
Thomas D. Schmittgen is a researcher affiliated with Professor of Pharmaceutics University of Florida, specializing in cancer, microRNA, molecular biology. Their work has been cited 257,652 times. This profile visualizes their global influence, highlighting strong citation networks in United States.
Thomas D. Schmittgen's Citation Metrics
Bibliometric impact based on 3 indexed publications.
- H-Index
- 56
- i10-Index
- 105
- Total Citations
- 257,652
- Citing Countries
- 4
As of May 2026.
Thomas D. Schmittgen has an h-index of 56 and 257,652 total citations across 3 publications, with research cited by institutions in 4 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Thomas D. Schmittgen's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
We've mapped 5,000 of 257,652 citations for Thomas D. Schmittgen
We've shown the most-cited 5,000. Unlock the full crawl (257,637 more citations) to see every institution citing this scholar.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Top Cited Works
Tip: clickto hide a row from the map
Analysis of relative gene expression data using real-time quantitative PCR and the $2^{-\Delta\Delta C_T}$ method
2001204,465
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
6 citing papers could not be classified (no author data) — excluded from the percentages above.
The researcher developed the $2^{- riangle riangle C_T}$ method for analyzing relative gene expression via real-time quantitative PCR, establishing a standard analytical framework widely adopted across the life sciences.
The researcher developed a standardized comparative CT method for analyzing real-time PCR data, establishing a widely adopted protocol that significantly advanced quantitative molecular biology techniques.
The researcher pioneered the detection of microRNA expression in human peripheral blood microvesicles, establishing a foundational method for liquid biopsy research as evidenced by nearly 2,000 citations.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
